All lobbying filings

Brownstein Hyatt Farber Schreck, LLP

Brownstein Hyatt Farber Schreck, LLP filed a Q3 report for Moderna US Inc. on October 16, 2025, reporting $80,000 in lobbying income.

Lobbying for Moderna US Inc. · Pharmaceuticals

As filed: BROWNSTEIN HYATT FARBER SCHRECK, LLP for MODERNA US INC.

All filings by Brownstein Hyatt Farber Schreck, LLP · Everything Moderna US Inc. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 16, 2025

Income

$80,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 1

Executive Office of the President (EOP)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to drug discovery, drug development, vaccine technologies, and coverage and reimbursement Issues related to biotechnology legislation and supply chain

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.